HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Raffaele De Caterina Selected Research

Thromboembolism

9/2022Response to "Non-vitamin K antagonist oral anticoagulants (NOACs) in preventing thromboembolism in atrial fibrillation patients with moderate to severe mitral stenosis: Results from a pilot trial".
2/2021Efficacy and safety of edoxaban in patients early after surgical bioprosthetic valve implantation or valve repair: A randomized clinical trial.
1/2019Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies.
9/2018Mechanical prosthetic heart valves: Quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study.
1/2018Symptom Burden of Atrial Fibrillation and Its Relation to Interventions and Outcome in Europe.
1/2018Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study).
1/2018Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy.
4/2017Non-Vitamin K Antagonist Oral Anticoagulants for Cardioversion in Atrial Fibrillation: An Updated Meta-analysis.
1/2017Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves.
11/2016[Ten questions awaiting for a definitive answer on the use of non-vitamin K oral anticoagulants in atrial fibrillation].
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Raffaele De Caterina Research Topics

Disease

95Atrial Fibrillation
10/2022 - 07/2004
79Hemorrhage
06/2022 - 03/2007
69Stroke (Strokes)
06/2022 - 05/2008
40Atherosclerosis
01/2022 - 03/2002
38Cardiovascular Diseases (Cardiovascular Disease)
10/2021 - 04/2003
34Myocardial Infarction
04/2022 - 09/2003
32Thrombosis (Thrombus)
03/2022 - 01/2005
31Acute Coronary Syndrome
02/2021 - 03/2004
22Inflammation (Inflammations)
10/2021 - 07/2002
20Heart Failure
06/2022 - 04/2003
19Embolism (Embolus)
01/2021 - 05/2006
18Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 03/2008
15Thromboembolism
09/2022 - 07/2004
12Coronary Disease (Coronary Heart Disease)
12/2021 - 01/2006
12Hypertension (High Blood Pressure)
01/2021 - 10/2009
12Ischemia
01/2016 - 06/2005
11Neoplasms (Cancer)
05/2021 - 11/2012
10Heart Diseases (Heart Disease)
10/2021 - 04/2005
9ST Elevation Myocardial Infarction
04/2022 - 10/2005
8Insulin Resistance
10/2021 - 02/2009
8Venous Thromboembolism
12/2019 - 09/2013
7Necrosis
11/2021 - 07/2005
7Infarction (Infarctions)
01/2021 - 05/2006
7Ischemic Stroke
01/2021 - 08/2011
7Atherosclerotic Plaque (Atheroma)
06/2020 - 05/2006
6Chronic Renal Insufficiency
09/2022 - 02/2010
6Myocardial Ischemia (Ischemic Heart Diseases)
10/2019 - 07/2006
5Mitral Valve Stenosis (Mitral Stenosis)
09/2022 - 08/2015
5Body Weight (Weight, Body)
06/2022 - 07/2014
5Intracranial Hemorrhages (Intracranial Hemorrhage)
02/2021 - 05/2014
5Type 2 Diabetes Mellitus (MODY)
01/2021 - 02/2009
5Transient Ischemic Attack
11/2020 - 05/2014
5Hyperglycemia
01/2020 - 02/2004
5Diabetes Mellitus
01/2019 - 02/2004
5Heart Valve Diseases (Valvular Heart Disease)
10/2018 - 08/2015
4Cardiotoxicity
01/2022 - 06/2013
4Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2021 - 02/2009
4Obesity
10/2021 - 01/2015
4COVID-19
01/2021 - 10/2020
4Hypoxia (Hypoxemia)
10/2019 - 01/2003
4Vascular Diseases (Vascular Disease)
01/2018 - 01/2012
4Pathologic Constriction (Stenosis)
11/2016 - 04/2003
3Frailty
10/2022 - 01/2018

Drug/Important Bio-Agent (IBA)

66AnticoagulantsIBA
10/2022 - 04/2007
47Vitamin KFDA Link
09/2022 - 06/2009
38Warfarin (Coumadin)FDA LinkGeneric
01/2022 - 07/2004
38Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2021 - 04/2003
28edoxabanIBA
10/2022 - 09/2013
26apixabanIBA
01/2022 - 08/2011
15Pharmaceutical PreparationsIBA
11/2020 - 04/2003
12Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2014
12LipidsIBA
12/2021 - 01/2006
11Insulin (Novolin)FDA Link
06/2022 - 09/2008
11CytokinesIBA
11/2021 - 11/2004
10CholesterolIBA
12/2021 - 04/2005
10DabigatranFDA Link
01/2021 - 04/2012
10Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
11/2020 - 01/2004
10Clopidogrel (Plavix)FDA Link
12/2017 - 07/2004
10Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
06/2011 - 03/2002
9N(4)-oleylcytosine arabinosideIBA
06/2022 - 01/2016
8omega-Chloroacetophenone (Mace)IBA
08/2021 - 10/2016
8AntioxidantsIBA
05/2020 - 03/2002
8Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
02/2020 - 04/2005
7RivaroxabanIBA
01/2022 - 04/2012
7Proteins (Proteins, Gene)FDA Link
11/2021 - 02/2002
7LDL CholesterolIBA
04/2021 - 01/2006
6TroponinIBA
10/2021 - 04/2012
6CreatinineIBA
01/2021 - 05/2014
6Olive OilIBA
05/2020 - 04/2003
6Biological ProductsIBA
10/2017 - 04/2003
5erucylphosphocholineIBA
01/2022 - 11/2008
5C-Reactive ProteinIBA
01/2021 - 10/2009
5PolyphenolsIBA
05/2020 - 04/2003
5Glycoproteins (Glycoprotein)IBA
11/2016 - 03/2004
5Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
11/2012 - 09/2006
5Advanced Glycation End ProductsIBA
03/2011 - 02/2002
5Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
08/2010 - 09/2003
4oxidized low density lipoproteinIBA
10/2021 - 09/2012
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2021 - 10/2009
4Growth Differentiation Factor 15IBA
01/2021 - 11/2014
4Enoxaparin (Lovenox)FDA LinkGeneric
11/2020 - 03/2007
4Hemoglobins (Hemoglobin)IBA
01/2020 - 10/2003
4Glucose (Dextrose)FDA LinkGeneric
01/2020 - 10/2013
4Matrix Metalloproteinases (MMPs)IBA
11/2019 - 05/2010
4EnzymesIBA
11/2019 - 10/2007
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 07/2002
4Thromboplastin (Tissue Factor)IBA
11/2016 - 07/2003
4Platelet Membrane Glycoprotein IIbIBA
11/2016 - 04/2004
32'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
04/2022 - 07/2020
3Factor Xa (Coagulation Factor Xa)IBA
01/2022 - 03/2017

Therapy/Procedure

77Therapeutics
10/2022 - 03/2004
24Percutaneous Coronary Intervention
01/2022 - 05/2006
15Stents
08/2020 - 09/2004
11Secondary Prevention
02/2021 - 04/2003
10Electric Countershock (Cardioversion)
11/2020 - 06/2016
7Drug-Eluting Stents
01/2022 - 09/2004
5Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2018 - 03/2007
4Myocardial Revascularization
01/2022 - 10/2013
4Mediterranean Diet
05/2020 - 04/2003
4Transplantation
10/2015 - 01/2012